This inventor holds 1 USPTO granted patent, plus 1 CIPO patent and 1 EPO patent. Top assignee: Chemo-Sero-Therapeutic Research Institute. Active years: 2017.
Company Filing History:
Years Active: 2017
Title: The Innovations of Mika Okuda
Introduction
Mika Okuda is a notable inventor based in Kumamoto, Japan. She has made significant contributions to the field of medical technology, particularly in the preparation of fibrinogen. Her innovative work has the potential to enhance clinical applications and improve patient outcomes.
Latest Patents
Mika Okuda holds a patent for a solid fibrinogen preparation. This preparation boasts improved solubility and can be produced quickly for use in clinical settings. The solid fibrinogen composition includes fibrinogen as the main ingredient, along with albumin, a nonionic surfactant, a basic amino acid or its salt, and at least two amino acids or their salts selected from an acidic amino acid and a neutral amino acid. This innovative composition can be held on a medical material to create a supporting material that holds fibrinogen. Furthermore, this supporting material can be combined with thrombin to produce a fibrin adhesive.
Career Highlights
Mika Okuda is associated with the Chemo-Sero-Therapeutic Research Institute, where she continues to advance her research and development efforts. Her work is characterized by a commitment to improving medical treatments and technologies.
Collaborations
Mika has collaborated with esteemed colleagues such as Tsutomu Hamuro and Shinichi Miyagawa. These partnerships have fostered a collaborative environment that enhances innovation and research outcomes.
Conclusion
Mika Okuda's contributions to the field of medical technology through her innovative fibrinogen preparation highlight her role as a leading inventor. Her work not only showcases her expertise but also has the potential to significantly impact clinical practices.